ER-Low and ER-Negative Breast Cancers Show Similar Chemotherapy Response and Survival
A multicenter study of 1,266 patients reveals that ER-low and ER-0 HER2-negative breast cancers achieve comparable chemotherapy response and short-term ...
A multicenter study of 1,266 patients reveals that ER-low and ER-0 HER2-negative breast cancers achieve comparable chemotherapy response and short-term ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.